000 01115nam a2200301 a 4500
005 20250914123430.0
008 020708s2002 xxk 001 0 eng b
020 _a0632045868
_cRM216.38
039 9 _a200210081521
_brozlinah
_c200208221108
_drozlinah
_c200207310846
_dlinda
_y07-08-2002
_zzaleha
060 _aQZ39
090 _aQZ39.C655p 2002
100 1 _aCobert, Barton L.
245 1 0 _aPharmacovigilange from A to Z :
_badverse drug event surveillance /
_cBarton L. Cobert, Pierre Biron
260 _aOxford :
_bBlackwell Science,
_c2002
300 _a235 p. ;
_c28 cm.
504 _aIncludes bibliographical references
650 1 2 _aPharmacoepidemiology
_vhandbooks
650 2 _aProduct Surveillance, Postmarketing
_vhandbooks
650 2 _aPharmaceutical Preparations
_xadverse effects
_vhandbooks
650 2 _aRisk Assessment
_vhandbooks
700 1 _aBiron, Pierre
907 _a.b13047176
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQZ39.C655p 2002
914 _avtls000317138
991 _aJabatan Farmasi, HUKM
998 _ah
_b2002-08-07
_cm
_da
_feng
_gxxk
_y0
_z.b13047176
999 _c304550
_d304550